Posaconazole for the prophylaxis of invasive aspergillosis in acute myeloid leukemia: Is it still useful outside the clinical trial setting?
Tsung-Chih ChenRen Ching WangYu-Hui LinKuang-Hsi ChangLi-Ya HungChieh-Lin Jerry TengPublished in: Therapeutic advances in hematology (2020)
Successful induction remains fundamental to reducing the risk of IA among AML patients undergoing remission induction chemotherapy.